Ana Lilia H.

MEXICO CITY - BARCELONA - PARIS Scientific Leader | Global Medical Strategist | Business Developer International Medical Doctor (M.D., MBA) with 12+ years’ experience driving Medical Communications and Strategy, Business Growth and Cross-functional Alignment across global agencies. Proven track record in medical excellence, stakeholder engagement, and end-to-end strategic leadership across nearly every therapeutic area and major pharma company worldwide. Proficient in MLR governance and AI-supported medical content workflows, ensuring compliant, efficient, and scalable operations across highly regulated healthcare environments. Therapeutic lines I've had the opportunity to work with: Aesthetics, Allergology, Cardiology, CNS, Gastroenterology, Gynaecology, Haematology, Hepatology, Immunology, Infectiology, Medical Devices, Neurology, Neonatology, Obstetrics, Oncology, Otorhinolaryngology, Paediatrics, Pneumology, Psychiatry, Rare Diseases, Urology & Virology. Portfolio (OTC, RX & CHC): Abbott Pharmaceuticals & Consumer Health, Abbvie, Asofarma, AstraZeneca, Armstrong, Alfa Wassermann, Bayer Pharmaceuticals & Consumer Health, Becton Dickinson, Bristol Myers Squibb, Boehringer Ingelheim, Carnot, Celgene, Chiesi, Commonwealth Laboratories, CSL, Danone Nutricia, Exeltis Pharma, Ferrer, GlaxoSmithKline, Grin, Grünenthal, Ipsen, J&J, Lupin, Liomont, Lundbeck, Mead Johnson Nutrition, Menarini, Merck, Merz, Merz Aesthetics, MSD, Mylan, Novartis, Novo Nordisk, Shire, Omron, Organon, Pfizer, P&G, Roche, Sandoz, Sanfer Prescription Products & Animal Health Products, Sanofi Aventis, Senosiain, Siegfried Rhein, Sifi, Silanes, Stendhal, Takeda, Valeant Grossman & Wyeth, and Teva.